TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32891291

Group type: EXPERIMENTAL
Intervention: Foot massage and patient education
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study: 33863454

Group type: EXPERIMENTAL
Intervention: Covered cryo-cabin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Open cryo-cabin
Number of subjects: 18
Study: 35876447

Group type: EXPERIMENTAL
Intervention: Art therapy intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34661774

Group type: EXPERIMENTAL
Intervention: Graftless sinus augmentation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional sinus augmentation (autografts and xenografts)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Prosthetic rehabilitation
Number of subjects: 10
Study: 32381162

Group type: EXPERIMENTAL
Intervention: Atrial septal aneurysm (ASA) with large PFO
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Atrial septal aneurysm (ASA) with nonlarge PFO
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Large PFO without ASA
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Nonlarge PFO without ASA
Number of subjects: 898

Group type: COMPARATOR
Intervention: Medical therapy (antithrombotic therapy)
Number of subjects: 898
Study: 35894448

Group type: EXPERIMENTAL
Intervention: ICG-fluorescent imaging
Number of subjects: 102

Group type: COMPARATOR
Intervention: 99m Tc-nanocoilloid
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both ICG and 99m Tc-nanocoilloid
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: ICG-fluorescent imaging and 99m Tc-nanocoilloid
Number of subjects: 102
Study: 33449509

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 32846768

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise combined with standardized drug therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine exercise combined with standardized drug therapy
Number of subjects: 64
Study: 36084280

Group type: EXPERIMENTAL
Intervention: Community group interventions
Number of subjects: 5927

Group type: EXPERIMENTAL
Intervention: Facility interventions package
Number of subjects: 5927

Group type: EXPERIMENTAL
Intervention: Community group intervention
Number of subjects: 5927

Group type: COMPARATOR
Intervention: Community group and facility intervention
Number of subjects: 5927

Group type: COMPARATOR
Intervention: Community group and facility interventions
Number of subjects: 5927
Study: 35977716

Group type: EXPERIMENTAL
Intervention: Head constrained using a head, neck, and chest brace which restricted neck movement
Number of subjects: 12

Group type: COMPARATOR
Intervention: No head constraint (control condition)
Number of subjects: 12
Study: 34521390

Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 5380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5380
Study: 35947305

Group type: EXPERIMENTAL
Intervention: Endoscopists viewing slides with information on polyp size and location
Number of subjects: 7

Group type: COMPARATOR
Intervention: Endoscopists viewing slides without information on polyp size and location
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Endoscopists with ≥ 10 years of colonoscopy experience
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Endoscopists evaluating inter-observer agreement
Number of subjects: 7
Study: 35641218

Group type: EXPERIMENTAL
Intervention: Nivolumab (n = 50)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Investigator's choice (IC) of chemotherapy (n = 26)
Number of subjects: 361
Study: 32037284

Group type: EXPERIMENTAL
Intervention: Nutritional Counseling (NC)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 107
Study: 34537494

Group type: EXPERIMENTAL
Intervention: SPECT/CT aided botulinum toxin injection
Number of subjects: 108
Study: 33198663

Group type: EXPERIMENTAL
Intervention: Cervical cerclage for short cervix in women at high risk of preterm birth following a fully dilated caesarean section.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current predictive models of preterm birth based on transvaginal ultrasound and quantitative fetal fibronectin.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational study evaluating subsequent pregnancy risk of preterm birth.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRI and transvaginal ultrasound imaging of cervical features.
Number of subjects: 0
Study: 35259978

Group type: COMPARATOR
Intervention: Topiramate monotherapy 100 mg/day (group A)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Topiramate plus greater occipital nerve block with 40 mg lidocaine (2%) and 80mg (2 ml) methylprednisolone (group B)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Topiramate plus greater occipital nerve block with 40 mg lidocaine (2%) injections monthly for 3 months (group C)
Number of subjects: 125
Study: 32413595

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Combination therapy (COMB)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Antidepressant medications (MEDs)
Number of subjects: 439
Study: 35773950

Group type: EXPERIMENTAL
Intervention: Intimate partner violence intervention in Nurse-Family Partnership programme
Number of subjects: 7
Study: 33607007

Group type: EXPERIMENTAL
Intervention: Sildenafil added to pirfenidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32854838

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan (S/V)
Number of subjects: 881

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 881
Study: 34378245

Group type: EXPERIMENTAL
Intervention: Fuzuloparib 50 mg (test preparation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Reference preparations (10 mg, 40 mg, 100 mg)
Number of subjects: 40
Study: 32111264

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg once daily for 6 months
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Matching placebo capsules once daily for 6 months
Number of subjects: 1500
Study: 33610080

Group type: EXPERIMENTAL
Intervention: Tissue adhesives (TA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adhesive dressing (AD)
Number of subjects: 0
Study: 32552153

Group type: EXPERIMENTAL
Intervention: Empagliflozin/linagliptin combination
Number of subjects: 2895

Group type: EXPERIMENTAL
Intervention: Empagliflozin monotherapy
Number of subjects: 2895

Group type: EXPERIMENTAL
Intervention: Linagliptin monotherapy
Number of subjects: 2895
Study: 35979677

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study: 34327687

Group type: EXPERIMENTAL
Intervention: Head circumference (HC) classified as small normal (5th‐10th percentile)
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Head circumference (HC) classified as normal (10th‐90th percentile)
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Head circumference (HC) classified as large normal (90th‐95th percentile)
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Continuous variable of head circumference (1 cm increase)
Number of subjects: 1236
Study: 33112433

Group type: EXPERIMENTAL
Intervention: 50mg daily oral avanafil
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 32925959

Group type: EXPERIMENTAL
Intervention: e-bike
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: longtail bike
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: traditional bike
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (car use)
Number of subjects: 18
Study: 34479835

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (400 mg/d)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Clonazepam (0.5 mg/d)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine and clonazepam
Number of subjects: 160
Study: 32067256

Group type: EXPERIMENTAL
Intervention: Ciclosporin (n = 26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (n = 26, control group)
Number of subjects: 52
Study: 33919779

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich meal (CARB; 1 g/kg CHO)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Protein-rich meal (PROTEIN; 0.45 g/kg protein + 0.24 g/kg fat)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Water (FASTED)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: All interventions (CARB, PROTEIN, FASTED)
Number of subjects: 17
Study: 34453570

Group type: EXPERIMENTAL
Intervention: Mobile application group (M-group)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Handout group (H-group)
Number of subjects: 82
Study: 33607805

Group type: EXPERIMENTAL
Intervention: Scoliosis surgery and diaphragmatic breathing and pursed lip exercises (Group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scoliosis surgery (Group 2)
Number of subjects: 30
Study: 32762224

Group type: EXPERIMENTAL
Intervention: High-intensity intermittent training
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine aerobic exercise
Number of subjects: 300
Study: 36051926

Group type: EXPERIMENTAL
Intervention: Ceftazidime combined with piperacillin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined group (Ceftazidime + Piperacillin)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (50 healthy subjects)
Number of subjects: 150
Study: 33709483

Group type: EXPERIMENTAL
Intervention: Bioimpedance analysis (BIA)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Clinical assessment
Number of subjects: 132
Study: 32161942

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) sampling
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: NRT sampling
Number of subjects: 57

Group type: COMPARATOR
Intervention: Referral-Only intervention
Number of subjects: 57
Study: 36197880

Group type: EXPERIMENTAL
Intervention: Contact with a dog
Number of subjects: 21

Group type: COMPARATOR
Intervention: Plush animal (control)
Number of subjects: 21
Study: 33754864

Group type: EXPERIMENTAL
Intervention: Conidial suspensions of L. biglobosa 'brassicae' and 'canadensis' (10 μL, 1 × 10^7 conidia mL‐1) inoculated on needle‐wounded cotyledons of B. napus cultivar Zhongshuang No. 9.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Water inoculation on needle‐wounded cotyledons (control group).
Number of subjects: 19
Study: 36123106

Group type: EXPERIMENTAL
Intervention: Communities That HEAL (CTH) intervention
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Community action planning process
Number of subjects: 67
Study: 34280733

Group type: EXPERIMENTAL
Intervention: AstraZeneca vaccine
Number of subjects: 1012

Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 1012

Group type: EXPERIMENTAL
Intervention: General population post vaccination
Number of subjects: 1012

Group type: EXPERIMENTAL
Intervention: General population
Number of subjects: 1012
Study: 34021092

Group type: EXPERIMENTAL
Intervention: Phase-change athletic cooling vest
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardized training/playing ensemble (control)
Number of subjects: 0
Study: 32558726

Group type: EXPERIMENTAL
Intervention: Prolonged suppressive valacyclovir
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 34487043

Group type: EXPERIMENTAL
Intervention: Active-site rTMS (n=20)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control-site rTMS (n=7)
Number of subjects: 20
Study: 32183775

Group type: EXPERIMENTAL
Intervention: Digital communication tool for non-German-speaking patients
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group 1 (German-speaking patients)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group 2 (non-German-speaking patients treated without the tool)
Number of subjects: 3
Study: 35594122

Group type: EXPERIMENTAL
Intervention: Multimedia educational tool (MET)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Routine care (RC)
Number of subjects: 380
Study: 34218184

Group type: EXPERIMENTAL
Intervention: Portable HEPA filter air cleaners
Number of subjects: 480

Group type: COMPARATOR
Intervention: No air cleaners (Control)
Number of subjects: 480
Study: 36123113

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) medication (Epidiolex)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 33905350

Group type: EXPERIMENTAL
Intervention: Multidimensional family therapy (MDFT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Family therapy as usual (FTAU)
Number of subjects: 42
Study: 32734606

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 9323

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9323

Group type: EXPERIMENTAL
Intervention: NRT
Number of subjects: 9323
Study: 33120482

Group type: EXPERIMENTAL
Intervention: Clotrimazole vaginal expansion suppository (150 mg) daily at night for 7 days
Number of subjects: 211

Group type: COMPARATOR
Intervention: Clotrimazole vaginal tablet (500 mg) single dose
Number of subjects: 211
Study: 36330106

Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing delivered via instant messaging
Number of subjects: 60

Group type: COMPARATOR
Intervention: Smoking cessation booklet
Number of subjects: 60
Study: 33380165

Group type: EXPERIMENTAL
Intervention: Confusion assessment method
Number of subjects: 141

Group type: COMPARATOR
Intervention: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: National Institutes of Health Stroke Scale
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Stroke-induced disorientation
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Neglect
Number of subjects: 141
Study: 32339648

Group type: EXPERIMENTAL
Intervention: Avelumab plus axitinib (10 mg/kg intravenously every 2 weeks plus 5 mg orally twice daily)
Number of subjects: 886

Group type: COMPARATOR
Intervention: Sunitinib (50 mg orally once daily for 4 weeks)
Number of subjects: 886

Group type: EXPERIMENTAL
Intervention: Avelumab plus axitinib
Number of subjects: 886

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 886
Study: 35244042

Group type: EXPERIMENTAL
Intervention: A‐LRYNGO (channel-type video-laryngoscope with AI-based glottis guidance system)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: McGrath laryngoscope
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pentax Airway-Scope
Number of subjects: 30
Study: 34166117

Group type: EXPERIMENTAL
Intervention: Blepharoplasty with internal browpexy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Blepharoplasty alone (control)
Number of subjects: 62
Study: 34127547

Group type: EXPERIMENTAL
Intervention: Missed Diagnostic Opportunities (MDOs) identified through case note reviews
Number of subjects: 2057

Group type: EXPERIMENTAL
Intervention: Contributing process breakdowns in MDOs
Number of subjects: 2057

Group type: EXPERIMENTAL
Intervention: Moderate to severe avoidable patient harm from MDOs
Number of subjects: 2057

Group type: EXPERIMENTAL
Intervention: Inter-reviewer agreement on MDOs
Number of subjects: 2057
Study: 32115517

Group type: EXPERIMENTAL
Intervention: Ipragliflozin 50 mg once daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control therapy
Number of subjects: 30
Study: 36053447

Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Conventional Fluid Therapy (Control)
Number of subjects: 137
Study: 34403892

Group type: EXPERIMENTAL
Intervention: Shiatsu massage (three 5-minute periods with a 2-minute break)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Touch on the area considered for the massage (control group)
Number of subjects: 68
Study: 36217159

Group type: EXPERIMENTAL
Intervention: Rectal artesunate (RAS)
Number of subjects: 6286

Group type: COMPARATOR
Intervention: Post-referral parenteral antimalarials plus oral artemisinin-based combination therapy (ACT)
Number of subjects: 6286
Study: 34100542

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 32862264

Group type: EXPERIMENTAL
Intervention: Plant oil (PO) - Linseed oil (LSO)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Plant oil (PO) - Corn oil (CO)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control - Fish oil (FO)
Number of subjects: 360
Study: 35998706

Group type: EXPERIMENTAL
Intervention: Multimodal-telemonitoring group
Number of subjects: 168

Group type: COMPARATOR
Intervention: Usual-CPAP-telemonitoring group
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 168
Study: 33632022

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 92

Group type: COMPARATOR
Intervention: Healthy Dietary Advice (HDA)
Number of subjects: 92
Study: 32278779

Group type: EXPERIMENTAL
Intervention: Inhaled regimens aligning with GOLD recommendations
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: Potential overtreatment
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid treatment
Number of subjects: 738

Group type: COMPARATOR
Intervention: Composite outcome (time to death or first hospitalization for COPD)
Number of subjects: 738
Study: 35908345

Group type: EXPERIMENTAL
Intervention: Menthol cigarettes (preference)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Non-menthol cigarettes (preference)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Higher nicotine content cigarettes (NNC vs VLNC)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Menthol preference
Number of subjects: 87
Study: 33994285

Group type: EXPERIMENTAL
Intervention: Viscoelastic support surface
Number of subjects: 72

Group type: COMPARATOR
Intervention: Gel support surface
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard operating table
Number of subjects: 72
Study: 33530854

Group type: EXPERIMENTAL
Intervention: Chia seeds (40 g/day for 12 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no supplement)
Number of subjects: 42
Study: 33843376

Group type: EXPERIMENTAL
Intervention: Exercise training (3 days a week for 10 weeks, 60-90 minutes each session)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (no regular exercise)
Number of subjects: 23
Study: 32278572

Group type: EXPERIMENTAL
Intervention: Pediatric Quality of Life Inventory (PedsQL)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Intracranial hemorrhage progression assessed by brain imaging
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Blood product transfusion requirements
Number of subjects: 91
Study: 32250444

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation device (NMES)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Compression stockings
Number of subjects: 28
Study: 34851445

Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T3, Tetronine®) 1 μg/kg-body weight/dose every 6 hours for 60 hours
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T3)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T3) in low-risk patients (Aristotle score < 10.0)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T3) in low-risk patients
Number of subjects: 120
Study: 32878448

Group type: EXPERIMENTAL
Intervention: FV-only weekly vouchers
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Household size effect
Number of subjects: 359
Study: 33316626

Group type: EXPERIMENTAL
Intervention: EPA 1 g/d
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: EPA 2 g/d
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: EPA 4 g/d
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 33099633

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) supplementation in AKI models (IRI)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) supplementation in CKD models
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) supplementation in human kidney allograft biopsies
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) supplementation in mice with UUO or chronic proteinuric glomerular disease
Number of subjects: 2
Study: 32147519

Group type: EXPERIMENTAL
Intervention: Postmastectomy hypofractionated radiation therapy (HFRT; 43.5 Gy in 15 fractions over 3 weeks)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Nadir-PLC/pre-PLC ratio <0.8
Number of subjects: 598

Group type: COMPARATOR
Intervention: Nadir-PLC/pre-PLC ratio ≥0.8
Number of subjects: 598
Study: 35685284

Group type: COMPARATOR
Intervention: normobaric hypoxia at FiO2 14.7% (NH15)
Number of subjects: 15

Group type: COMPARATOR
Intervention: normobaric hypoxia at FiO2 12.5% (NH13)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: normobaric normoxia (NN)
Number of subjects: 15
Study: 34068083

Group type: EXPERIMENTAL
Intervention: 12-weekly BTA dosing
Number of subjects: 263

Group type: COMPARATOR
Intervention: 4-weekly BTA dosing
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: De-escalation from 4-weekly to 12-weekly BTA
Number of subjects: 263
Study: 33827649

Group type: EXPERIMENTAL
Intervention: Specific acupoints (SA) group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Non‐specific acupoints (NSA) group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non‐acupoints (NA) group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups (SA, NSA, NA)
Number of subjects: 90
Study: 32052923

Group type: EXPERIMENTAL
Intervention: AVAPS-AE
Number of subjects: 69

Group type: COMPARATOR
Intervention: ST
Number of subjects: 69
Study: 33623999

Group type: EXPERIMENTAL
Intervention: EUROASPIRE Risk Model
Number of subjects: 12484